Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

BACKGROUND: Dose-dense sequential chemotherapy including anthracyclines and taxanes has been established in the adjuvant setting of high-risk operable breast cancer. However, the preferable taxane and optimal schedule of administration in a dose-dense regimen have not been defined yet. METHODS: From...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Fountzilas, George, Dafni, Urania, Papadimitriou, Christos, Timotheadou, Eleni, Gogas, Helen, Eleftheraki, Anastasia G, Xanthakis, Ioannis, Christodoulou, Christos, Koutras, Angelos, Papandreou, Christos N, Papakostas, Pavlos, Miliaras, Spyros, Markopoulos, Christos, Dimitrakakis, Constantine, Korantzopoulos, Panagiotis, Karanikiotis, Charisios, Bafaloukos, Dimitrios, Kosmidis, Paris, Samantas, Epaminontas, Varthalitis, Ioannis, Pavlidis, Nicholas, Pectasides, Dimitrios, Dimopoulos, Meletios-Athanassios
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223601/
https://ncbi.nlm.nih.gov/pubmed/25026897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados